期刊文献+

我院2001~2008年临床分离革兰阴性杆菌构成及其耐药性分析 被引量:6

Composition of Clinically Isolated Gram-negative Bacilli and Drug Resistance in Our Hospital from 2001~2008
原文传递
导出
摘要 目的:为临床医师合理使用抗菌药物提供可靠依据。方法:对我院2001~2008年临床分离革兰阴性(G-)杆菌及耐药情况进行回顾性调查。结果:2001~2008年临床共分离的病原菌14428株,G-杆菌9391株,占65.1%,主要以大肠埃希菌、铜绿假单胞菌、阴沟肠杆菌、肺炎克雷伯菌及不动杆菌多见,其中鲍曼不动杆菌分离率逐年上升。G-杆菌对临床常用抗菌药物均有不同程度耐药,对氨苄西林普遍耐药率高;对亚胺培南、哌拉西林/他唑巴坦、阿米卡星耐药率较低。结论:G-杆菌构成及耐药谱在不断发生变化,临床医师应掌握细菌变迁及细菌耐药性变化动向,提高抗菌药物合理使用水平。 OBJECTIVE: To provide clinicians with reliable basis about rational use of antibacterials. METHODS: The gram-negative bacilli isolated clinically in our hospital from 2001 to 2008 and their drug resistance were analyzed retrospectively. RESULTS: A total of 14 428 strains of pathogenic bacteria were isolated from 2001 to 2008, of which, 9 391 strains (65.1%) were gram-negative bacilli, leading the list were Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae and Acinetobacter, and the detected rate of Acinetobacter baurnannii increased year by year. Gram-negative bacilli were resistant to commonly used antibacterials more or less, with their resistance rates to ampicillin on the high side, but their resis- tance rates to imipenem, pipercillin/tazobactam and amikacin were low. CONCLUSION: The composition of clinically isolated Gram-negative bacilli and their drug resistance patterns were always in a change, therefore, clinicians should familiarize with this change as well as the change of drug resistance and improve their level of rational use of antibiotics.
出处 《中国药房》 CAS CSCD 北大核心 2010年第2期139-141,共3页 China Pharmacy
关键词 革兰阴性杆菌 超广谱Β-内酰胺酶 耐药性 抗菌药物 Gram-negative bacilli Extended-spectrum β-lactamase Drug resistance Antibacterials
  • 相关文献

参考文献8

二级参考文献45

共引文献456

同被引文献51

  • 1程训民,张琪,沈继录,朱素珍,李敏,徐元宏.产超广谱β-内酰胺酶表型及基因型分布[J].中华医院感染学杂志,2005,15(2):142-145. 被引量:35
  • 2王莉英,蒋军,唐震,何慧.我院2005年细菌耐药性监测与分析[J].中国药房,2007,18(2):125-127. 被引量:17
  • 3Itokazu GS,Quirm JP, Bell-Dixon C, et al. Antirnicrobial resistance rates among aerobic gram negative bacilli recovered from patients in intensive care traits: evaluation of a national postmarketing surveillance program[J]. Clin Infect Dis, 1996, 23(4): 779-784.
  • 4Giamarellou H, Antoniadou A. Antipseudomonal antibiotics. Med Clin North Amer, 2001, 85(1) : 19-42.
  • 5Lepper PM, Grusa E, Reich H, et al. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 2002, 46(9): 2920-2925.
  • 6Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics., penem resistance mechanisms and their interplay[J]. Antimicrob Agents Chemother, 2001, 45(7) : 1964-1971.
  • 7Waterer GW, Wunderink RG. Increasing threat of Gram negative bacteria[J]. Crit Care Med, 2001, 29 (Suppl 4): N75-N78.
  • 8Danes C, Navia MM, Ruiz J, et al. Distribution of beta lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different betalactam antibioties[J]. J Antimierob Chemother, 2002, 50(2): 261-264.
  • 9Henwood CJ, Gatward T, Warner M, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of Tigecydine (GAR-936)[J]. J Antimierob Chemother, 2002, 49(3): 479-487.
  • 10Nordmann P, Poirel L Emerging carbapenemases in Gram negative aerobes[J].Clin Microb Infect, 2002, 8(6): 321-331.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部